|
FR2260330A1
(en)
|
1974-02-07 |
1975-09-05 |
Innothera Lab Sa |
Pyridoxine N-oxy nicotinate - hypolipaemiant and hypocholesterolemiant of good therapeutic index
|
|
US4032526A
(en)
|
1975-10-02 |
1977-06-28 |
American Cyanamid Company |
1,2-dimethyl-3 or 5-piperazinyl-pyrazolium salts
|
|
US4426382A
(en)
|
1980-02-13 |
1984-01-17 |
Sankyo Company Limited |
4-Amino-6,7-dimethoxy-2-piperazinylquinazoline derivatives, their preparation and use
|
|
DE3517617A1
(de)
|
1985-05-15 |
1986-11-20 |
Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München |
Neue pyridaziniumverbindungen, verfahren zu deren herstellung und diese enthaltende fungizide und algizide mittel
|
|
DE69325662T2
(de)
|
1992-10-23 |
2000-02-10 |
Merck Sharp & Dohme Ltd., Hoddesdon |
Dopamin rezeptor subtyp liganden
|
|
US5629325A
(en)
|
1996-06-06 |
1997-05-13 |
Abbott Laboratories |
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
|
|
US6514977B1
(en)
|
1997-05-22 |
2003-02-04 |
G.D. Searle & Company |
Substituted pyrazoles as p38 kinase inhibitors
|
|
US6979686B1
(en)
|
2001-12-07 |
2005-12-27 |
Pharmacia Corporation |
Substituted pyrazoles as p38 kinase inhibitors
|
|
EE04588B1
(et)
|
1997-10-27 |
2006-02-15 |
Neurosearch A/S |
Heteroarüüldiasatsükloalkaanid kui atsetüülkoliini nikotiinretseptorite kolinergilised ligandid, nende kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon
|
|
US6143892A
(en)
|
1998-11-20 |
2000-11-07 |
G. D. Searle & Co. |
Process for making 5-substituted pyrazoles
|
|
US6248755B1
(en)
|
1999-04-06 |
2001-06-19 |
Merck & Co., Inc. |
Pyrrolidine modulators of chemokine receptor activity
|
|
SK287418B6
(sk)
|
1999-05-04 |
2010-09-07 |
Schering Corporation |
Farmaceutický prípravok s obsahom CCR5 antagonistov a súprava s obsahom tohto prípravku
|
|
GB0004153D0
(en)
|
2000-02-23 |
2000-04-12 |
Astrazeneca Uk Ltd |
Novel use
|
|
OA12274A
(en)
|
2000-05-22 |
2006-05-09 |
Aventis Pharma Inc |
Arylmethylamine derivatives for use as tryptase inhibitors.
|
|
WO2002030928A1
(de)
|
2000-10-12 |
2002-04-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Kristallines monohydrat, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels
|
|
AR035700A1
(es)
|
2001-05-08 |
2004-06-23 |
Astrazeneca Ab |
Derivados de arilheteroalquilamina, composicion farmaceutica, usos de estos derivados para la fabricacion de medicamentos, metodos de tratamiento, y proceso para la preparacion de estos derivados
|
|
ME00412B
(me)
|
2001-06-22 |
2011-10-10 |
Boehringer Ingelheim Pharma |
Kristalni antiholinergik , postupak za njegovo pripremanje i njegova primjena u proizvodnji lijeka
|
|
WO2003037271A2
(en)
|
2001-10-30 |
2003-05-08 |
Millennium Pharmaceuticals,Inc. |
Compounds, pharmaceutical compositions and methods of use therefor
|
|
US6806279B2
(en)
|
2001-12-17 |
2004-10-19 |
Sunesis Pharmaceuticals, Inc. |
Small-molecule inhibitors of interleukin-2
|
|
EP1474401A2
(en)
|
2002-02-05 |
2004-11-10 |
Novo Nordisk A/S |
Novel aryl- and heteroarylpiperazines
|
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
|
CN100445276C
(zh)
|
2002-03-13 |
2008-12-24 |
詹森药业有限公司 |
用作组蛋白去乙酰酶抑制剂的磺酰基衍生物
|
|
US20040014744A1
(en)
|
2002-04-05 |
2004-01-22 |
Fortuna Haviv |
Substituted pyridines having antiangiogenic activity
|
|
EP1501507B1
(en)
*
|
2002-04-29 |
2008-05-28 |
Merck & Co., Inc. |
Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
|
|
TW200400960A
(en)
|
2002-06-05 |
2004-01-16 |
Pharmacia Corp |
Novel pyrazoles and their use as P38 kinase inhibitors
|
|
AU2003270199A1
(en)
|
2002-09-13 |
2004-04-30 |
Glaxo Group Limited |
Urea compounds active as vanilloid receptor antagonists for the treatment of pain
|
|
SE0203304D0
(sv)
|
2002-11-07 |
2002-11-07 |
Astrazeneca Ab |
Novel Coumpounds
|
|
GB0229618D0
(en)
|
2002-12-19 |
2003-01-22 |
Cancer Rec Tech Ltd |
Pyrazole compounds
|
|
WO2004074438A2
(en)
|
2003-02-14 |
2004-09-02 |
Smithkline Beecham Corporation |
Ccr8 antagonists
|
|
PL1633724T3
(pl)
|
2003-03-12 |
2011-10-31 |
Kudos Pharm Ltd |
Pochodne ftalazynonu
|
|
CA2523431A1
(en)
|
2003-04-23 |
2004-11-25 |
Glaxo Group Limited |
Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
|
|
FR2854158B1
(fr)
|
2003-04-25 |
2006-11-17 |
Sanofi Synthelabo |
Derives de 2-acylamino-4-phenylethiazole, leur preparation et leur application en therapeutique
|
|
JP2006528147A
(ja)
|
2003-07-18 |
2006-12-14 |
グラクソ グループ リミテッド |
ヒスタミンｈ３受容体リガンドとしての置換ピペリジン
|
|
WO2005009976A1
(en)
*
|
2003-07-29 |
2005-02-03 |
Novo Nordisk A/S |
Pyridazinyl- piperazines and their use as histamine h3 receptor ligands
|
|
KR20080052683A
(ko)
|
2003-12-18 |
2008-06-11 |
인사이트 코포레이션 |
케모킨 수용체의 조절제로서의3-사이클로알킬아미노피롤리딘 유도체
|
|
US7435830B2
(en)
|
2004-03-03 |
2008-10-14 |
Chemocentryx, Inc. |
Bicyclic and bridged nitrogen heterocycles
|
|
US7423147B2
(en)
|
2004-03-31 |
2008-09-09 |
Janssen Pharmaceutical, N.V. |
Pyridine compounds as histamine H3 modulators
|
|
WO2005117909A2
(en)
|
2004-04-23 |
2005-12-15 |
Exelixis, Inc. |
Kinase modulators and methods of use
|
|
WO2006001958A2
(en)
|
2004-05-21 |
2006-01-05 |
Merck & Co., Inc. |
Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity
|
|
CA2569016C
(en)
|
2004-06-02 |
2012-11-27 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compound
|
|
US8071624B2
(en)
|
2004-06-24 |
2011-12-06 |
Incyte Corporation |
N-substituted piperidines and their use as pharmaceuticals
|
|
WO2006012135A1
(en)
|
2004-06-24 |
2006-02-02 |
Janssen Pharmaceutica, N. V. |
Quaternary salt ccr2 antagonists
|
|
WO2006004741A2
(en)
|
2004-06-28 |
2006-01-12 |
Incyte Corporation |
3-aminocyclopentanecarboxamides as modulators of chemokine receptors
|
|
JP2008510783A
(ja)
|
2004-08-26 |
2008-04-10 |
クドス ファーマシューティカルズ リミテッド |
４−ヘテロアリールメチル置換フタラジノン誘導体
|
|
GB0420831D0
(en)
|
2004-09-17 |
2004-10-20 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0421525D0
(en)
|
2004-09-28 |
2004-10-27 |
Novartis Ag |
Inhibitors of protein kineses
|
|
WO2006038734A1
(en)
|
2004-10-08 |
2006-04-13 |
Astellas Pharma Inc. |
Pyridazinone derivatives cytokines inhibitors
|
|
CA2589106C
(en)
|
2004-11-02 |
2015-07-21 |
Northwestern University |
Pyridazine compounds, compositions and methods and their use in treating inflammatory diseases
|
|
DE102004061751A1
(de)
|
2004-12-22 |
2006-07-06 |
Bayer Healthcare Ag |
Cyanoguanidin-substituierte Pyrazoline
|
|
TWI385164B
(zh)
|
2005-02-17 |
2013-02-11 |
Astellas Pharma Inc |
Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivatives (II)
|
|
JP2008537953A
(ja)
|
2005-04-15 |
2008-10-02 |
エラン ファーマシューティカルズ，インコーポレイテッド |
ブラジキニンｂ１受容体拮抗作用に有用な新規化合物
|
|
TW200716594A
(en)
|
2005-04-18 |
2007-05-01 |
Neurogen Corp |
Substituted heteroaryl CB1 antagonists
|
|
EP2354140A1
(en)
|
2005-05-20 |
2011-08-10 |
Vertex Pharmaceuticals Incorporated |
Pyrrolopyridines useful as inhibitors of protein kinase
|
|
MX2007015675A
(es)
|
2005-07-04 |
2008-02-20 |
Novo Nordisk As |
Antagonistas del receptor de histamina h3.
|
|
US7851474B2
(en)
|
2005-08-02 |
2010-12-14 |
Neurogen Corporation |
Dipiperazinyl ketones and related analogues
|
|
GB0517184D0
(en)
|
2005-08-22 |
2005-09-28 |
Glaxo Group Ltd |
Compounds
|
|
AR055203A1
(es)
|
2005-08-31 |
2007-08-08 |
Otsuka Pharma Co Ltd |
Derivados de benzotiofeno con propiedades antipsicoticas
|
|
KR101415426B1
(ko)
|
2005-09-27 |
2014-07-04 |
아이알엠 엘엘씨 |
디아릴아민-함유 화합물 및 조성물, 및 ｃ-ｋｉｔ 수용체의조절제로서의 그의 용도
|
|
US8067457B2
(en)
|
2005-11-01 |
2011-11-29 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as antagonists of CCR2
|
|
WO2007053495A2
(en)
|
2005-11-01 |
2007-05-10 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as antagonists of ccr2
|
|
CN101309915A
(zh)
|
2005-11-14 |
2008-11-19 |
Irm责任有限公司 |
作为lxr调节剂的化合物和组合物
|
|
WO2007084868A2
(en)
|
2006-01-17 |
2007-07-26 |
Kalypsys, Inc. |
Treatment of disorders by activation of the unfolded protein response
|
|
JO2660B1
(en)
|
2006-01-20 |
2012-06-17 |
نوفارتيس ايه جي |
Pi-3 inhibitors and methods of use
|
|
NZ570847A
(en)
|
2006-02-28 |
2011-10-28 |
Helicon Therapeutics Inc |
Therapeutic compounds
|
|
WO2007105058A2
(en)
|
2006-03-16 |
2007-09-20 |
Pfizer Products Inc. |
Pyrazole compounds
|
|
WO2007120574A2
(en)
|
2006-04-11 |
2007-10-25 |
Merck & Co., Inc. |
Diaryl substituted alkanes
|
|
US7807671B2
(en)
|
2006-04-25 |
2010-10-05 |
Bristol-Myers Squibb Company |
Diketo-piperazine and piperidine derivatives as antiviral agents
|
|
US20100168120A1
(en)
|
2006-04-28 |
2010-07-01 |
Neuromedix Inc. |
Salts of pyridazine compounds
|
|
US20080039450A1
(en)
|
2006-06-22 |
2008-02-14 |
Jensen Annika J |
Compounds
|
|
ES2548353T3
(es)
|
2006-12-28 |
2015-10-15 |
Abbvie Inc. |
Inhibidores de poli(ADP-ribosa)polimerasa
|
|
CA2676715A1
(en)
|
2007-02-12 |
2008-08-21 |
Merck & Co., Inc. |
Piperazine derivatives for treatment of ad and related conditions
|
|
JP4785881B2
(ja)
|
2007-02-27 |
2011-10-05 |
大塚製薬株式会社 |
医薬
|
|
JP5603770B2
(ja)
|
2007-05-31 |
2014-10-08 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｃｃｒ２受容体拮抗薬およびその使用
|
|
MX2010002005A
(es)
|
2007-08-22 |
2010-03-11 |
Irm Llc |
Derivados de 2-heteroaril-amino-pirimidina como inhibidores de cinasa.
|
|
RU2010116821A
(ru)
|
2007-10-01 |
2011-11-10 |
Ф.Хоффманн-Ля Аг (Ch) |
N-гетероциклические биарильные карбоксамиды в качестве антагонистов рецептора ccr
|
|
RU2487127C2
(ru)
|
2007-10-09 |
2013-07-10 |
Ф.Хоффманн-Ля Рош Аг |
Хиральные цис-имидазолины
|
|
US20090131417A1
(en)
|
2007-11-20 |
2009-05-21 |
Letavic Michael A |
Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
|
|
US8829006B2
(en)
|
2007-11-22 |
2014-09-09 |
Boehringer Ingelheim International Gmbh |
Compounds
|
|
EP2062889A1
(de)
|
2007-11-22 |
2009-05-27 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Verbindungen
|
|
AU2009259496A1
(en)
|
2008-06-18 |
2009-12-23 |
F. Hoffmann-La Roche Ag |
Novel heteroaryl carboxamide derivatives
|
|
JP5693452B2
(ja)
|
2008-08-04 |
2015-04-01 |
シーエイチディーアイ ファウンデーション，インコーポレーテッド |
特定のキヌレニン−３−モノオキシゲナーゼインヒビター、医薬組成物およびそれらの使用方法
|
|
GB0815369D0
(en)
|
2008-08-22 |
2008-10-01 |
Summit Corp Plc |
Compounds for treatment of duchenne muscular dystrophy
|
|
AU2009289378A1
(en)
|
2008-09-02 |
2010-03-11 |
Boehringer Ingelheim International Gmbh |
Novel benzamides, production thereof, and use thereof as medicaments
|
|
CN102256963B
(zh)
|
2008-12-19 |
2014-06-11 |
贝林格尔.英格海姆国际有限公司 |
作为ccr2受体拮抗剂用于治疗炎症、哮喘和copd的环状嘧啶-4-甲酰胺
|
|
US20110301143A1
(en)
|
2009-02-23 |
2011-12-08 |
Elise Isabel |
Heterocyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
ES2674275T3
(es)
|
2009-12-17 |
2018-06-28 |
Centrexion Therapeutics Corporation |
Antagonistas del receptor CCR2 y usos de los mismos
|
|
EP2513086B1
(en)
|
2009-12-17 |
2015-04-29 |
Boehringer Ingelheim International GmbH |
Novel antagonists for ccr2 and uses thereof
|
|
WO2011141474A1
(en)
|
2010-05-12 |
2011-11-17 |
Boehringer Ingelheim International Gmbh |
Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
|
|
JP5646736B2
(ja)
|
2010-05-12 |
2014-12-24 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規ｃｃｒ２受容体アンタゴニスト、これらの製造方法、及び薬物としてのこれらの使用
|
|
WO2011144501A1
(en)
|
2010-05-17 |
2011-11-24 |
Boehringer Ingelheim International Gmbh |
Ccr2 antagonists and uses thereof
|
|
WO2011147772A1
(en)
|
2010-05-25 |
2011-12-01 |
Boehringer Ingelheim International Gmbh |
Ccr2 receptor antagonists
|
|
US8962656B2
(en)
|
2010-06-01 |
2015-02-24 |
Boehringer Ingelheim International Gmbh |
CCR2 antagonists
|
|
WO2012171863A1
(en)
|
2011-06-16 |
2012-12-20 |
Boehringer Ingelheim International Gmbh |
New selective ccr2 antagonists
|
|
EP2731941B1
(en)
|
2011-07-15 |
2019-05-08 |
Boehringer Ingelheim International GmbH |
Novel and selective ccr2 antagonists
|